September 3, 2023

Hello there, Respiratory disease can be taxing to deal with. Would you want to know a bit about it?   It is any illness that affects the airways and lungs, impacting human respiration. Around 545 million people worldwide suffer from chronic respiratory disease, ranging from common colds to conditions like asthma, pneumonia, and influenza.   […]

0
By Dr. Emmanuel Egbroko
September 1, 2023

  According to a publication in Vaccines Today, in France, trained pharmacists will be permitted to prescribe and administer vaccines.   Pharmacists played a major role in the uptake of the COVID-19 vaccines, and they’ve been granted permission to administer shots against diphtheria, tetanus, polio, pertussis, flu, HPV, measles, mumps, rubella, hepatitis A, hepatitis B, […]

0
By Dr. Emmanuel Egbroko
August 31, 2023

  Paxlovid the antiviral medication developed by Pfizer remains a very important tool in our fight against COVID-19. This medication is important in saving the lives of patients for several reasons.   First, Paxlovid is an effective oral medication against COVID. This means it can easily be self administered by patients if guided by knowledgeable […]

0
By Dr. Emmanuel Egbroko
August 31, 2023

  A Pretoria High Court dismisses application brought by a physician association (IPA Foundation) that aimed at preventing pharmacists from managing and prescribing medicines to patients with HIV and tuberculosis.    The approval means Patients Living With HIV (PLWH) will have increased access to their medicines at pharmacies that are taking part in the Pharmacy […]

0
By Dr. Emmanuel Egbroko
August 31, 2023

  Pfizer gets the Food and Drug Administration (FDA) approval for her vaccine against the Respiratory Syncytial Virus (RSV). The vaccine will help protect infants, pregnant women, and individuals 60 years and above from the harmful effects of RSV.   RSV is a very infectious virus that affects the lungs and can lead to life […]

0
By Dr. Emmanuel Egbroko
July 28, 2023

Introduction Paxlovid is an oral antiviral medication developed by Pfizer for the treatment of corona virus disease. To get the benefits of the medication you will have to take it for the recommended period. How is Paxlovid packaged This simply is how the medication is packed in its pack and sachet. One sachet of the […]

0
By Dr. Emmanuel Egbroko
July 17, 2023

  Research findings says people who took Paxlovid are less likely to have long COVID symptoms. The article was published in March 2023 in JAMA Internal Medicine. It revealed that high-risk patients who took Paxlovid within five days of confirming infection for COVID-19 were 26% less likely to have Long COVID symptoms after 90 days, compared […]

0
By Dr. Emmanuel Egbroko
July 17, 2023

   Jennifer Lorenzini/Reuters   The U.S Food and Drug Administration (FDA) approves Paxlovid for the treatment of mild-to-moderate COVID-19. In a press release On May 25, 2023, the FDA granted Pfizer approval for its antiviral medication for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including […]

0
By Dr. Emmanuel Egbroko
July 15, 2023

  Paxlovid reduces risk of severe COVID-19 in patients with chronic health condition a new study finds. The study which was conducted by researchers at Harvard University was published in June 2023 in the Clinical Infectious Diseases Journal. This investigation will contribute to proper use of the antiviral medication in the treatment of patients in […]

0
By Dr. Emmanuel Egbroko